Citadel Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$232K Buy
+20,000
New +$249K ﹤0.01% 11095
2025
Q4
Sell
-22,300
Closed -$283K 14278
2025
Q3
$283K Buy
22,300
+600
+3% +$8.71K ﹤0.01% 10513
2025
Q2
$345K Sell
21,700
-32,900
-60% -$492K ﹤0.01% 9475
2025
Q1
$816K Sell
54,600
-146,200
-73% -$2.59M ﹤0.01% 7395
2024
Q4
$3.81M Sell
200,800
-29,800
-13% -$630K ﹤0.01% 4420
2024
Q3
$6.24M Buy
230,600
+164,500
+249% +$4.2M ﹤0.01% 3599
2024
Q2
$1.65M Buy
66,100
+61,400
+1,306% +$1.76M ﹤0.01% 5678
2024
Q1
$156K Sell
4,700
-12,600
-73% -$430K ﹤0.01% 10709
2023
Q4
$616K Buy
17,300
+12,500
+260% +$397K ﹤0.01% 7648
2023
Q3
$164K Sell
4,800
-34,700
-88% -$1.32M ﹤0.01% 10213
2023
Q2
$1.58M Buy
39,500
+20,100
+104% +$799K ﹤0.01% 5582
2023
Q1
$762K Sell
19,400
-9,500
-33% -$349K ﹤0.01% 7387
2022
Q4
$920K Buy
28,900
+18,200
+170% +$549K ﹤0.01% 6972
2022
Q3
$303K Sell
10,700
-11,100
-51% -$379K ﹤0.01% 9570
2022
Q2
$779K Buy
21,800
+12,500
+134% +$505K ﹤0.01% 7603
2022
Q1
$458K Sell
9,300
-52,100
-85% -$2.75M ﹤0.01% 9603
2021
Q4
$3.43M Sell
61,400
-55,300
-47% -$3.04M ﹤0.01% 5082
2021
Q3
$6.77M Buy
116,700
+46,300
+66% +$2.85M ﹤0.01% 3741
2021
Q2
$4.45M Sell
70,400
-1,300
-2% -$85.6K ﹤0.01% 4687
2021
Q1
$4.58M Sell
71,700
-74,000
-51% -$4.29M ﹤0.01% 4448
2020
Q4
$7.63M Sell
145,700
-14,200
-9% -$700K ﹤0.01% 3014
2020
Q3
$6.99M Sell
159,900
-55,100
-26% -$2.44M ﹤0.01% 2704
2020
Q2
$9.47M Buy
215,000
+136,300
+173% +$5.76M ﹤0.01% 2284
2020
Q1
$3.06M Buy
78,700
+33,200
+73% +$1.69M ﹤0.01% 3436
2019
Q4
$2.58M Sell
45,500
-15,300
-25% -$853K ﹤0.01% 4017
2019
Q3
$3.24M Buy
60,800
+1,100
+2% +$59.1K ﹤0.01% 3726
2019
Q2
$3.48M Sell
59,700
-95,600
-62% -$5.14M ﹤0.01% 3618
2019
Q1
$7.7M Buy
155,300
+101,600
+189% +$4.47M ﹤0.01% 2388
2018
Q4
$2M Sell
53,700
-3,600
-6% -$131K ﹤0.01% 4151
2018
Q3
$2.16M Buy
57,300
+52,100
+1,002% +$2.17M ﹤0.01% 4277
2018
Q2
$228K Sell
5,200
-4,700
-47% -$221K ﹤0.01% 7671
2018
Q1
$498K Sell
9,900
-15,300
-61% -$901K ﹤0.01% 5895
2017
Q4
$1.66M Buy
25,200
+14,300
+131% +$909K ﹤0.01% 3901
2017
Q3
$652K Buy
10,900
+1,800
+20% +$107K ﹤0.01% 4945
2017
Q2
$590K Buy
9,100
+1,500
+20% +$94.8K ﹤0.01% 4888
2017
Q1
$475K Buy
7,600
+1,100
+17% +$66.2K ﹤0.01% 5119
2016
Q4
$375K Buy
6,500
+400
+7% +$23.6K ﹤0.01% 5346
2016
Q3
$363K Buy
6,100
+1,000
+20% +$61.4K ﹤0.01% 5360
2016
Q2
$316K Sell
5,100
-13,300
-72% -$819K ﹤0.01% 5130
2016
Q1
$1.13M Buy
18,400
+9,500
+107% +$560K ﹤0.01% 3335
2015
Q4
$542K Buy
8,900
+1,300
+17% +$77.3K ﹤0.01% 4371
2015
Q3
$384K Buy
7,600
+7,000
+1,167% +$373K ﹤0.01% 5183
2015
Q2
$31K Sell
600
-6,200
-91% -$321K ﹤0.01% 7944
2015
Q1
$346K Sell
6,800
-9,100
-57% -$469K ﹤0.01% 5456
2014
Q4
$847K Buy
15,900
+14,800
+1,345% +$753K ﹤0.01% 3967
2014
Q3
$50K Sell
1,100
-5,800
-84% -$273K ﹤0.01% 6904
2014
Q2
$327K Buy
6,900
+2,500
+57% +$116K ﹤0.01% 4947
2014
Q1
$203K Sell
4,400
-10,500
-70% -$486K ﹤0.01% 5496
2013
Q4
$722K Buy
14,900
+14,600
+4,867% +$683K ﹤0.01% 3569
2013
Q3
$13K Sell
300
-5,500
-95% -$235K ﹤0.01% 6395
2013
Q2
$238K Buy
+5,800
New +$242K ﹤0.01% 4512

Other funds holding XRAY

Citadel Advisors's XRAY Position: Q1 2026 in Review

Citadel Advisors reduced its Dentsply Sirona (XRAY) stake by 19% in Q1 2026, selling an estimated $4.19M and leaving 1,393,463 shares worth $16.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

Citadel Advisors first reported a position in XRAY in Q2 2013 and has held it in 51 quarters since. The position peaked at $127M in Q4 2023. 384 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Citadel Advisors held 1,393,463 shares of Dentsply Sirona worth $16.2M as of Q1 2026.
  • Citadel Advisors sold 336,184 Dentsply Sirona shares in Q1 2026, an estimated $4.19M.
  • Dentsply Sirona made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2599 holding.
  • Citadel Advisors first reported a position in Dentsply Sirona in Q2 2013 and has held it in 51 quarters since.
  • Citadel Advisors's Dentsply Sirona position peaked at $127M in Q4 2023.
  • 384 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.